Merger Milestone | Kellanova awaits regulatory approval for its transformative merger with Mars, reshaping its future in the competitive U.S. food industry landscape |
Financial Snapshot | Explore Kellanova's robust financial health, with $12.63B revenue, $2.37B EBITDA, and a 36.66% gross profit margin, despite merger-related guidance limitations |
Analyst Projections | Delve into EPS estimates ranging from $3.75 to $3.83 for FY2025 and $3.86 to $4.04 for FY2026, with an average price target of $83 from multiple analysts |
Strategic Synergies | Learn how the Mars merger could enhance Kellanova's market position, potentially unlocking R&D innovations, supply chain optimizations, and marketing efficiencies |
Metrics to compare | K | Sector Sector - Average of metrics from a broad group of related sector companies | Relationship RelationshipKPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | 22.7x | 11.4x | |
PEG Ratio | 0.00 | −2.91 | 0.03 | |
Price/Book | 0.0x | 4.8x | 1.5x | |
Price / LTM Sales | 0.0x | 2.2x | 0.9x | |
Upside (Analyst Target) | 0.0% | 18.5% | 26.5% | |
Fair Value Upside | Unlock | 10.5% | 14.5% | Unlock |